MoneyWorks4Me

Supriya Lifescience - Quaterly Results

20 May 2022 Evaluate
The sales figure stood at Rs. 1812.69 millions for the March 2022 quarter. The mentioned figure indicates a growth of about 37.21% as compared to Rs. 1321.07 millions during the year-ago period.The Company's Net profit for the March 2022 quarter have declined marginally to Rs. 462.12  millions as against Rs. 485.07 millions reported during the corresponding quarter ended.OP of the company witnessed a marginal growth to 790.78 millions from 686.68 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1812.69 1321.07 37.21 5300.49 3912.45 35.48 5300.49 3912.45 35.48
Other Income 38.55 15.02 156.66 75.77 49.77 52.24 75.77 49.77 52.24
PBIDT 790.78 686.68 15.16 2215.62 1781.51 24.37 2215.62 1781.51 24.37
Interest 10.17 12.42 -18.12 41.98 40.80 2.89 41.98 40.80 2.89
PBDT 780.61 674.26 15.77 2173.64 1740.71 24.87 2173.64 1740.71 24.87
Depreciation 25.79 17.84 44.56 101.18 67.61 49.65 101.18 67.61 49.65
PBT 754.82 656.42 14.99 2072.46 1673.10 23.87 2072.46 1673.10 23.87
TAX 292.70 171.35 70.82 554.35 437.16 26.81 554.35 437.16 26.81
Deferred Tax 108.25 -3.50 -3192.86 32.46 6.94 367.72 32.46 6.94 367.72
PAT 462.12 485.07 -4.73 1518.11 1235.94 22.83 1518.11 1235.94 22.83
Equity 160.97 146.37 9.97 160.97 146.37 9.97 160.97 146.37 9.97
PBIDTM(%) 43.62 51.98 -16.07 41.80 45.53 -8.20 41.80 45.53 -8.20
Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..